Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020998

« Back to Dashboard

NDA 020998 describes CELEBREX, which is a drug marketed by Gd Searle and is included in one NDA. It is available from twenty-four suppliers. Additional details are available on the CELEBREX profile page.

The generic ingredient in CELEBREX is celecoxib. There are twenty-six drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the celecoxib profile page.

Summary for 020998

Tradename:	CELEBREX
Applicant:	Gd Searle
Ingredient:	celecoxib
Patents:	0
Therapeutic Class:	Analgesics Anti-inflammatory Agents
Formulation / Manufacturing:	see details

Pharmacology for NDA: 020998

Ingredient-type	Nonsteroidal Anti-inflammatory Compounds
Mechanism of Action	Cyclooxygenase Inhibitors

Medical Subject Heading (MeSH) Categories for 020998

Cyclooxygenase 2 Inhibitors

Suppliers and Packaging for NDA: 020998

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
CELEBREX	celecoxib	CAPSULE;ORAL	020998	NDA	G.D. Searle LLC Division of Pfizer Inc	0025-1515	N	0025-1515-01
CELEBREX	celecoxib	CAPSULE;ORAL	020998	NDA	G.D. Searle LLC Division of Pfizer Inc	0025-1520	N	0025-1520-31

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	100MG
Approval Date:	Dec 31, 1998	TE:	AB	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	200MG
Approval Date:	Dec 31, 1998	TE:	AB	RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	400MG
Approval Date:	Aug 29, 2002	TE:	AB	RLD:	Yes

Expired US Patents for NDA 020998

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Gd Searle	CELEBREX	celecoxib	CAPSULE;ORAL	020998-001	Dec 31, 1998	➤ Try a Free Trial	➤ Try a Free Trial
Gd Searle	CELEBREX	celecoxib	CAPSULE;ORAL	020998-004	Dec 15, 2006	➤ Try a Free Trial	➤ Try a Free Trial
Gd Searle	CELEBREX	celecoxib	CAPSULE;ORAL	020998-004	Dec 15, 2006	➤ Try a Free Trial	➤ Try a Free Trial
Gd Searle	CELEBREX	celecoxib	CAPSULE;ORAL	020998-003	Aug 29, 2002	➤ Try a Free Trial	➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.